Introduction {#Sec1}
============

Modern western diets are characterized by deficiency in content of polyunsaturated fatty acids (PUFA), in particular low consumption of fish in favor of baked and junk food has led to altered n-6/n-3 PUFA ratio. Interestingly, it has been estimated that from the dawn of the industrial revolution, the ratio n-6/n-3 has dramatically increased. Indeed, such value moved from 1, typical of early twentieth century, up to 15 in industrialized countries \[[@CR1]--[@CR3]\]. While n-3 PUFA are precursors of neuroprotectins and resolvins holding anti-inflammatory properties, n-6 PUFA are precursors, among others, of prostaglandins é, pro-inflammatory molecules responsible for modulating the activity of inflammatory cytokines. Biologically important PUFA, such as docosahexaenoic acid (DHA, 22:6n-3) and arachidonic acid (AA, 20:4n-6), can be supplied either directly from diet or by metabolic conversion of their essential precursors α-linolenic acid (18:3n-3) and linoleic acid (18:2n-6), respectively. While in mammals, the synthesis of such precursors cannot be performed de novo, the enzymatic conversion relies on the action of two desaturases, Δ5 and Δ6 present on the endoplasmic reticulum, and retroconversion of DHA takes then place in peroxisomes. Although in mammals such enzymatic elongation is possibly occurring, some evidence has underlined that in humans this conversion may result inefficient, thus tissue concentrations of these lipids are closely related to diet intake \[[@CR4]\]. The n-6 derivative, AA, plays a crucial physiological role being an important precursor of bioactive mediators. This molecule has been shown to activate protein kinases and ion channels leading to enhanced synaptic transmission \[[@CR5]\]. Moreover, AA-derived mediators have been shown to act as retrograde messengers in hippocampal long-term potentiation \[[@CR6], [@CR7]\] and to be involved in cortical neuron migration \[[@CR8]\].

N-3 PUFA have been reported to regulate membrane fluidity and to exert their central action by modulating synaptogenesis and neurotrophic factor expression \[[@CR9]\]. Indeed, these lipids are essential to assure proper brain functioning considering that DHA content is higher in cerebral rather than any other tissue \[[@CR10]\].

On the other hand, the high ratio n-6/n-3 is particularly unfavorable for proper central nervous system (CNS) functioning. Indeed, when diets are particularly poor in n-3 PUFA, endoreticulum, as well as peroxisomes, metabolically produce n-6 derivatives, namely n-6 docosapentaenoic acid (22:5n-6), whose insertion into biological membranes, in place of DHA, is considered the main process responsible of CNS dysfunction \[[@CR11]\].

It is worth to note that, during embryonic life and lactation, PUFA intake exclusively depends on maternal diet, as the metabolic conversion of essential precursors cannot be accomplished \[[@CR12]\]. Interestingly, evidence from human studies indicates that maternal metabolic state and malnutrition influence dramatically the risk for developing psychiatric complications in later adulthood \[[@CR13]\]. Unfortunately, it is quite reasonable to assume that this nutritional-poor diet will be later perpetuated, considering that it represents part of a lifestyle acquired during early childhood. Accordingly, epidemiological evidences have established a negative correlation between n-3 PUFA consumption and development of anxiety, depression, as well as physiological distress \[[@CR14]--[@CR16]\]. These findings were supported by clinical studies indicating that low content of n-3 PUFA in diet is linked to an increased susceptibility to psychiatric disorders like depression \[[@CR17], [@CR18]\]. In addition, n-3 supplementation alone or in adjunctive therapies showed positive results in the treatment of this mental disorder \[[@CR19]\]. Such beneficial effects were also endorsed in a recent updated meta-analysis of randomized controlled trials investigating the efficacy of n-3 PUFA treatment in depressive disorders \[[@CR20]\], as indicated by recent guidelines from British Association for Psychopharmacology \[[@CR21]\].

Recently, great importance has been given to soluble beta amyloid~1--42~ (Aβ~1--42~) peptide in the development of depression \[[@CR22], [@CR23]\]. Indeed, it is known that some forms of depression, particularly in elderly, may represent prodromal manifestations of Alzheimer's Disease (AD), or alternatively a subtype of a mood disorder associated to amyloid burden, featured by cognitive impairment and risk of dementia \[[@CR24]\].

In this context, chronic stress is another environmental risk factor for the development of depressive symptoms. In this regard, dysregulation of hypothalamic--pituitary-adrenal (HPA) axis in response to chronic or repeated stressful events has been reported as a crucial mechanism \[[@CR25]\]. Low cerebral DHA content, secondary to poor diet, has been associated to increased anxiety-like behavior induced by chronic mild stress paradigm in animals \[[@CR26]\]. Accordingly, it has been reported that a diet enriched in n-6 fatty acids increased aggressive behavior in rodents, while high n-3 PUFA diet was able to reduce the stress response \[[@CR27], [@CR28]\], indicating that also n-6 PUFA content plays a central role.

Therefore, in the present study we evaluated the effects of pre- and post-natal exposure to diet enriched in either n-3 or n-6 PUFA, as well as to n-6/n-3 balanced diet, as controls, in male rat offspring. In particular, we evaluated the development of depressive and anxiety-like behaviors in rats, corroborating behavioral outcomes with measures of plasmatic Aβ levels, HPA axis parameters, and monoamine concentrations in prefrontal cortex (PFC), a brain region crucial in depression and where DHA plays a major role in neural maturation \[[@CR29]\].

Materials and Methods {#Sec2}
=====================

Animals {#Sec3}
-------

Adult (250--300 g) Wistar rats (Harlan, S. Pietro al Natisone, Udine) were used in this study. They were housed at constant room temperature (22 ± 1 °C) and relative humidity (55 ± 5 %) under a 12-h light/dark cycle with ad libitum access to food and water. Procedures involving animals and their care were conducted in conformity with the institutional guidelines of the Italian Ministry of Health (D.L. 26/2014), the Guide for the Care and Use of Mammals in Neuroscience and Behavioral Research (National Research Council 2004), the Directive 2010/63/EU of the European Parliament and of the Council of 22 September 2010 on the protection of animals used for scientific purposes. All procedures involving animals were conducted in accordance to ARRIVE guidelines. Animal welfare was daily monitored through the entire period of experimental procedures. No signs of distress were evidenced, anyway all efforts were made to minimize the number of animals used and their suffering.

Diets {#Sec4}
-----

One male and two female rats were housed together for mating. Animals were exposed to specific diets mimicking lifelong n-6/n-3 imbalance of PUFA as previously described \[[@CR12], [@CR30]\]. In particular, after mating dams were randomly assigned to the group fed with either a diet containing 6 % total fat in the form of only rapeseed oil (n-3 enriched, rich in linolenic acid 18:3n-3) or peanut oil (n-6 enriched, rich in linoleic acid 18:2n-6) throughout gestation and lactation. As control group, dams were fed with a diet containing 6 % total fat in the form of 3 % of peanut oil plus 3 % of rapeseed oil, called n-6/n-3 diet. After weaning, offsprings continued to be subjected to the same diet throughout life. All experiments were then performed in male 8-week-old rats.

Open Field Spontaneous Locomotor Activity {#Sec5}
-----------------------------------------

The open field (OF) apparatus consisted of a circular arena, 75 cm diameter, made of dark plastic under dim lighting, as previously described by Monteggia et al. \[[@CR31]\]. The experimental sessions were videotaped by a camera fixed above the arena. Animals were acclimatized to the test room for 1 h before each test. Motor activity was measured by placing the rat into the center of the arena before a 20-min session. The scoring was performed using a video-tracking motion analysis system (ANY-MAZE, San Diego Instrument, San Diego, CA). To assess general locomotor activity, the following behavioral parameters (expressed as frequency on 5 min counts) were scored: number of square limit crossings with both forepaws, rearing (standing with the body inclined vertically, forequarters raised), and wall rearing (standing on the hind limbs and touching the walls of the apparatus with the forelimbs). To investigate anxiety-related behavior, we measured time spent performing general grooming activity consisting of the following: face grooming (strokes along the snout), head washing (semicircular movements over the top of the head and behind the ears), and body grooming (body fur licking) \[[@CR32]\]. Time spent in center and periphery was quantified as measure of anxiety-like behavior.

Forced Swimming Test {#Sec6}
--------------------

The forced swimming test (FST) is a reliable task for discriminating depressive state in animals and is widely used for predicting antidepressant properties of drugs \[[@CR33]\]. On the first of the two test days, animals were placed individually in inescapable Perspex cylinders (diameter 23 cm; height 70 cm) filled with water at constant temperature of 25 ± 1 °C at 30 cm of height \[[@CR34]\].

During the preconditioning period, animals were videotaped for 15 min. Then, rats were removed and dried before being returned to their home cages. Twenty-four hours later, each rat was positioned in the water-filled cylinder for 5 min. This session was video-recorded and subsequently scored by an observer blind to the treatment groups. During the test sessions, the frequency that the rats spent performing the following behaviors was measured: struggling (time spent in tentative of escaping), swimming (time spent moving around the cylinder), and immobility (time spent remaining afloat making only the necessary movements to keep its head above the water). Data were expressed as frequency on 5 s counts.

Post-Mortem Tissue Analysis {#Sec7}
---------------------------

Rats were euthanized and brains were immediately removed and cooled on ice for dissection of target regions (PFC, hypothalamus) according to the atlas of Paxinos and Watson (1998). Tissues were frozen and stored at −80 °C until analysis was performed.

Monoamine Quantifications {#Sec8}
-------------------------

Serotonin (5-HT) and noradrenaline (NA) concentrations were determined by high performance liquid chromatography (HPLC) coupled with an electrochemical detector (Ultimate ECD, Dionex Scientific, Milan, Italy). Separation was performed by a LC18 reverse phase column (Kinetex, 150 × 4.2 mm, ODS 5 μm; Phenomenex, Castel Maggiore- Bologna, Italy). The detection was accomplished by a thin-layer amperometric cell (Dionex, ThermoScientifics, Milan, Italy) with a 5-mm diameter glassy carbon electrode at a working potential of 0.400 V vs. Pd. The mobile phase used was 75 mM NaH~2~PO~4~, 1.7 mM octane sulfonic acid, 0.3 mM EDTA, acetonitrile 10 %, in distilled water, buffered at pH 3.0. The flow rate was maintained by an isocratic pump (Shimadzu LC-10 AD, Kyoto, Japan) at 1 ml/min. Data were acquired and integrated using Chromeleon software (version 6.80, Dionex, San Donato Milanese, Italy).

ELISA Quantifications {#Sec9}
---------------------

Plasma samples were analyzed for corticosterone and Aβ by using ELISA kits provided by Tebu-bio (Magenta, Milan, Italy) and Cloud-Clone Corporation (Houston, Texas, USA), respectively. Corticotropin-releasing factor (CRF) quantification was performed in hypothalamic area by using ELISA kits provided by Tebu-bio (Magenta, Milan, Italy). Assays were performed according to the manufacturer's instructions. Each sample analysis was carried out in duplicate to avoid intra-assay variations.

Statistical Analysis {#Sec10}
--------------------

Results were expressed as mean ± S.E.M. Statistical analyses were performed using Graph Pad 5.0 (GraphPad Software, San Diego, CA) for Windows. Behavioral and neurochemical data were tested for normality and then analyzed by using two-way analysis of variance (ANOVA) for repeated measures or one-way ANOVA followed by Bonferroni's or Tukey's multiple comparisons test, as required. Differences were considered statistically significant when *P* value was less than 0.05.

Results {#Sec11}
=======

Effects of N-3 and N-6 PUFA-Enriched Diets on Body Weight Gain {#Sec12}
--------------------------------------------------------------

Offspring rats fed with n-3, n-6 PUFA, and n-6/n-3 (control) diets were weekly weighted in order to monitor general health status. Analysis of data evidenced no differences in total body weight gain among groups (210.2 ± 5.0 g, 200.0 ± 3.3 g, 195.8 ± 5.0 g, for animals fed with n-6/n-3, n-3, and n-6 PUFA diet, respectively; one-way ANOVA followed by Tukey's multiple comparison test, n.s.). Moreover, we estimated the total food intake and no statistically significant differences were individuated (439.9 ± 74.2 g, 385.4 ± 61.8 g, 296.9 ± 74.8 g, for animals fed with n-6/n-3, n-3, and n-6 PUFA diets, respectively; one-way ANOVA followed by Tukey's multiple comparison test, n.s.)

Effects of N-3 and N-6 PUFA-Enriched Diets on FST {#Sec13}
-------------------------------------------------

In order to determine if pre- and post-natal exposure to either n-3 or n-6 PUFA-enriched diet was able to influence emotional behavior, we performed the FST on experimental groups. N-6 PUFA-enriched diet significantly increased the immobility frequency compared to control and n-3 PUFA rich diet (Fig. [1a](#Fig1){ref-type="fig"}, one-way ANOVA followed by Bonferroni's multiple comparison test, *P* \< 0.01 n-3 versus n-6 PUFA, and *P* \< 0.001 n-6 PUFA versus n-6/n-3 balanced diet). Moreover, swimming and struggling frequencies were significantly decreased in n-6 PUFA diet-exposed animals (Fig. [1b, c](#Fig1){ref-type="fig"}, one-way ANOVA followed by Bonferroni's multiple comparison test, swimming *P* \< 0.01 n-3 versus n-6 PUFA, and *P* \< 0.001 n-6 PUFA versus n-6/n-3 balanced diet; struggling *P* \< 0.01 n-6 PUFA versus n-6/n-3 balanced diet).Fig. 1Effects of n-3, n-6, and n-6/n-3 balanced PUFA diet on FST. Frequency measure of immobility (**a**), swimming (**b**), and struggling (**c**) behaviors in rats fed from conception until 5 weeks post-weaning with n-6/n-3 balanced diet (*white bar*), n-3 PUFA diet (*dark bar*), and n-6 PUFA diet (*gray bar*). Data are expressed as mean ± SEM. One-way ANOVA followed by Bonferroni's multiple comparison test \**P* \< 0.05, \*\**P* \< 0.01 versus n-3 PUFA and ^\#^ *P* \< 0.05, ^\#\#^ *P* \< 0.01 versus n-6/n-3 balanced diet

Effects of N-3 and N-6 PUFA-Enriched Diets on OF {#Sec14}
------------------------------------------------

In order to verify whether the effects observed in the FST could not be related to an alteration in locomotion, we accomplished the OF test. These experiments were carried out in another set of rats to avoid inter-assay interference. Statistical analyses revealed a significant effect only on time in crossing and wall rearing frequencies (Fig. [2a, c](#Fig2){ref-type="fig"}, two-way ANOVA for repeated measures, crossing *P* \< 0.001 F~3,21~ = 53.62; wall rearing *P* \< 0.001 F~3,21~ = 38.19). Moreover, no impairment associated to diet exposure was evidenced in either vertical or horizontal activity, as revealed by crossing, rearing, and wall rearing frequency measurements (Fig. [2a--c](#Fig2){ref-type="fig"}, two-way ANOVA for repeated measures followed by Bonferroni's multiple comparison test, n.s.). In the same test, self-grooming behavior was quantified as index of anxiety-like state. We found that n-6 PUFA diet significantly increased the time that rats spent performing self-grooming (Fig. [3a](#Fig3){ref-type="fig"}, one-way ANOVA followed by Bonferroni's multiple comparison test, *P* \< 0.05 n-6 versus n-3 PUFA and n-6/n-3 balanced diet). No differences were observed in the time spent in periphery or center area of the arena (Fig. [3b, c](#Fig3){ref-type="fig"}, one-way ANOVA followed by Bonferroni's multiple comparison test, n.s.).Fig. 2Effects of n-3, n-6, and n-6/n-3 balanced PUFA diet on locomotive index in OF. Frequency measure of crossing (**a**), rearing (**b**), and wall rearing (**c**) in rats fed from conception until 5 weeks post-weaning with n-6/n-3 balanced diet (*empty triangle*), n-3 PUFA diet (*empty circle*), and n-6 PUFA diet (*empty square*). Two-way ANOVA for repeated measures followed by Bonferroni's multiple comparison test Data are expressed as mean ± SEM Fig. 3Effects of n-3, n-6, and n-6/n-3 balanced PUFA diet on anxiety-like index in OF. Measure of time spent performing grooming (**a**), time in center (**b**), and in periphery (**c**) in rats fed from conception until 5 weeks post-weaning with n-6/n-3 balanced diet (*white bar*), n-3 PUFA diet (*dark bar*), and n-6 PUFA diet (*gray bar*). Data are expressed as mean ± SEM. One-way ANOVA followed by Bonferroni's multiple comparison test \**P* \< 0.05 versus n-3 PUFA and \#*P* \< 0.05 versus n-6/n-3 balanced diet

Effects of N-3 and N-6 PUFA-Enriched Diets on 5-HT and NA Levels in PFC {#Sec15}
-----------------------------------------------------------------------

In order to corroborate behavioral with neurochemical data, we quantified 5-HT and NA content in PFC of PUFA-enriched diet fed animals. We found that cortical 5-HT concentrations were significantly lower in animals pre- and post-natal fed with n-6 PUFA-enriched diet compared to controls (Fig. [4a](#Fig4){ref-type="fig"}, one-way ANOVA followed by Bonferroni's multiple comparison test, *P* \< 0.05). On the other hand, NA was significantly increased in n-3 PUFA-treated rats compared to either n-6 PUFA or controls animals (Fig. [4b](#Fig4){ref-type="fig"}, one-way ANOVA followed by Bonferroni's multiple comparison test, *P* \< 0.05).Fig. 4Effects of n-3, n-6, and n-3/n-6 balanced PUFA diet on cortical monoamine levels. Measure of 5-HT (**a**) and NA content (**b**) in PFC of rats fed from conception until 5 weeks post-weaning with n-6/n-3 balanced diet (*white bar*), n-3 PUFA diet (*dark bar*), and n-6 PUFA diet (*gray bar*). One-way ANOVA followed by Tukey's multiple comparison test data are expressed as mean ± SEM. \**P* \< 0.05 versus n-3 PUFA and \#*P* \< 0.05 versus n-6/n-3 balanced diet

Effects of N-3 and N-6 PUFA-Enriched Diets on HPA Axis {#Sec16}
------------------------------------------------------

We quantified hypothalamic CRF and plasmatic corticosterone levels. We found that CRF content was significantly increased after n-6 PUFA in respect to control diet (Fig. [5a](#Fig5){ref-type="fig"}, one-way ANOVA followed by Bonferroni's multiple comparison test, *P* \< 0.05 n-6 PUFA fed rats versus balanced diet controls). Accordingly, n-6 PUFA diet was also able to enhance corticosterone levels compared to n-3 PUFA-treated and controls animals (Fig. [5b](#Fig5){ref-type="fig"}, one-way ANOVA followed by Bonferroni's multiple comparison test, *P* \< 0.05).Fig. 5Effects of n-3, n-6, and n-6/n-3 balanced PUFA diet on hypothalamic CRF and plasmatic corticosterone quantification. Measure of hypothalamic CRF content (**a**) and plasmatic corticosterone levels (**b**) in rats fed from conception until 5 weeks post-weaning with n-6/n-3 balanced diet (*white bar*), n-3 PUFA diet (*dark bar*), and n-6 PUFA diet (*gray bar*). Data are expressed as mean ± SEM. One-way ANOVA followed by Tukey's multiple comparison test \**P* \< 0.05 versus n-3 PUFA and \#*P* \< 0.05 versus n-6/n-3 balanced diet

Effects of N-3 and N-6 PUFA-Enriched Diets on Plasmatic Aβ Levels {#Sec17}
-----------------------------------------------------------------

We quantified plasmatic soluble Aβ peptide in offspring of rats differently exposed to n-3, n-6 PUFA, and n-6/n-3 balanced diets. We found that, while animals exposed throughout their life to n-6 PUFA-enriched diet had a significant increase in plasmatic Aβ levels compared to controls, high n-3 PUFA diet significantly decreased such levels (Fig. [6](#Fig6){ref-type="fig"}, one-way ANOVA followed by Bonferroni's multiple comparison test, *P* \< 0.001 n-6 PUFA versus n-6/n-3 and *P* \< 0.05 n-3 and n-6 PUFA versus n-6/n-3, respectively).Fig. 6Effects of n-3, n-6, and n-6/n-3 balanced PUFA diet on plasmatic Aβ~1--42~ quantification. Measure of plasmatic Aβ~1--42~ in rats fed from conception until 5 weeks post-weaning with n-6/n-3 balanced diet (*white bar*), n-3 PUFA diet (*dark bar*), and n-6 PUFA diet (*gray bar*). Data are expressed as mean ± SEM. One-way ANOVA followed by Tukey's multiple comparison test \**P* \< 0.05 and \*\*\**P* \< 0.001 versus n-3 PUFA and \#*P* \< 0.05 versus n-6/n-3 balanced diet

Discussion {#Sec18}
==========

In the present study, we evaluated the effects of pre- and post-natal rat exposure to n-3 and n-6 PUFA-enriched diets on behavioral outcomes resembling human depressive- and anxiety-like symptoms. Our findings clearly indicated that exposure during entire life to a diet enriched in n-6 PUFA induced a depressive- and anxiety-like state in adult offspring. In these animals, behavioral outcomes were accompanied by hyperactivation of HPA axis, alteration of cortical monoamine content and increased plasmatic Aβ~1--42~ levels.

In our model, rats were fed with PUFA-enriched diets from conception until experimental day. This paradigm simulates human conditions where children are fed with poor n-3 PUFA diet during gestation, nursing, up to young adulthood. Here, we found that n-6 PUFA-enriched diet that should correspond to a depauperation of central n-3 fatty acids \[[@CR35]\] increased immobility frequency in the FST. This behavioral test relies on the learned helplessness paradigm that ultimately results in symptoms resembling depression. This behavioral paradigm is widely considered reliable for discriminating depressive-like state, as well as predicting antidepressant properties of drugs \[[@CR33]\]. We can rule out the possibility that such increased immobility could have been due to alteration in locomotion, since no impairment in vertical and horizontal activities was found in the OF test. On the other hand, the OF revealed that n-6 PUFA fed rats spent more time in performing self-grooming, an index of anxiety-like behavior in rodents \[[@CR36]\].

Our findings are in line with previous studies, in humans and animals, linking poor n-3 PUFA diet with depression and anxiety \[[@CR29], [@CR37]--[@CR39]\]. Many mechanisms have been proposed in order to explain such effects. Essential fatty acids play a central role in CNS, taking into account that long chain fatty acids, as DHA, are integrant part of neuronal membrane. They control membrane fluidity, as well as neuronal plasticity. Imbalance in maternal micronutrients has been found to reduce cortical DHA, and brain-derived neurothrophic factor (BDNF), while n-3 PUFA supplementation was shown to protect such neurotrophin. Furthermore, deficiency in n-3 PUFA intake, especially in perinatal period, is linked to decreased BDNF \[[@CR35]\] and low BDNF levels have been described after prenatal stress \[[@CR40]\]. Glucocorticoids have been related to such an effect, since corticosterone is able to down-regulate both mRNA and protein BDNF \[[@CR41], [@CR42]\]. In this light, mice over-expressing glucocorticoids showed an increased anxiety-like behavior \[[@CR43]\] and Larrieu and Colleagues have demonstrated that n-3 PUFA deficiency can influence neuronal cortical morphology and depressive-like behavior through corticosterone secretion \[[@CR39]\]. Furthermore, they showed that a condition of poor n-3 diet intake induces a phenotype comparable to one induced by chronic social defeat stress and high corticosterone levels were also described \[[@CR39]\]. Accordingly, in our model we found increased hypothalamic CRF release as well as increased plasmatic corticosterone levels in n-6 PUFA fed animals, further demonstrating a hyperactivity of HPA axis. High cortisol levels, and thus HPA-axis hyperactivity, have been indicated as the most frequent alteration in patients affected by major depression disorder \[[@CR44]\]. Supplementation of n-3 PUFA may thus result beneficial given the described prophylactic role in depression \[[@CR45]\]. On the other hand, another neurotrophic factor that has been implicated in the neurobiology of depression and chronic stress exposure is transforming-growth factor-β1 (TGF-β1) \[[@CR46]\]. TGF-β1 has a constitutive role in inflammation suppression and protects neuron from toxic insults in the CNS acting as neurotrophic factor \[[@CR46]\]. Furthermore, TGF-β1 may enhance synaptic plasticity via increased BDNF and its receptor, trkB, expression \[[@CR47]\]. In particular, reduced levels of this factor have been reported in major depressed patients and antidepressant treatments have been reported to increase TGF-β1 levels \[[@CR48]\]. Moreover, n-3 PUFA supplementation has been shown to increase TGF-β1 levels, both in vivo and in vitro \[[@CR49], [@CR50]\]. Thus, future studies are warranted in order to elucidate whether, in our experimental conditions, n-3 PUFA deficiency could lead to depressive state also by altering TGF-β1 signaling.

In addition, other mediators beyond neurotrophins could be rather implicated. Activation of endocannabinoid system, whose endogen ligands are derived from AA, seems to play a significant role in attenuating stress response and HPA axis stimulation \[[@CR51], [@CR52]\]. In addition, alterations in this system have been reported after poor maternal n-3 PUFA intake \[[@CR12]\]. Endocannabinoids control mood and emotional phenotype and depressive and anxiety-like behaviors have been shown to be improved by increasing their levels \[[@CR53], [@CR54]\].

In keeping with this hypothesis, prefrontal cortical endocannabinoids require functional serotonergic tone in order to promote active stress coping response \[[@CR55]\]. In our experimental conditions, we found that cortical 5-HT concentrations were significantly decreased in animals fed with n-6 PUFA diet. The PFC is the most enriched area in DHA and it has been shown that, after poor diet intake, this brain region is the most sensitive to DHA depauperation \[[@CR17]\]. Such low levels of 5-HT support behavioral outcomes. Indeed, immobility and swimming frequency in FST are regulated by serotonergic transmission. In particular, high 5-HT levels, consequent to selective re-uptake inhibitors, are commonly associated to increased swimming and reduced immobility behavior \[[@CR34], [@CR56]\]. In a recent publication, Patrick and Ames proposed a possible mechanism underlying the modulatory role of micronutrients, such as n-3 PUFA and vitamin D, on 5-HT synthesis \[[@CR57]\]. According to Authors, EPA enhances 5-HT release pre-synaptically through reduction of central prostaglandins of E2 series, responsible of inhibiting its release. Furthermore, DHA, by increasing cell membrane fluidity, facilitates 5-HT interaction with its receptors in postsynaptic neurons \[[@CR57]\]. Based on these data, it could be hypothesized that inflammation negatively affects central serotonergic system. In this regard, the anti-inflammatory effects of n-3 PUFA have been reported, since DHA was shown to reduce eicosanoid synthesis along with AA production \[[@CR58], [@CR59]\] and to decrease inflammatory cytokine levels \[[@CR60]\]. Furthermore, Madore and Colleagues have elegantly shown that n-3 deficiency during gestation and lactation leads to altered microglia motility, as well as altered microglia phenotype \[[@CR35]\], prompting these Authors to hypothesize that such deficiency induced a state that resembles the so-called pseudoinflammation or sterile inflammation, described in absence of pathogens \[[@CR61]\]. Reduction in 5-HT levels has also been linked to anxiety-like behavior, since genetic manipulations that lead to drastic 5-HT depauperation result in higher susceptibility to stress, while treatments that increase 5-HT result in a highly anxiolytic phenotype \[[@CR62], [@CR63]\]. Despite 5-HT role in anxiety is well established, NAergic role remains less defined. In particular, we found that after n-6 PUFA-enriched diet, no alterations were found in cortical NA content, although increased CRF and corticosterone levels. Thus, these data can be considered as an impairment of stress response axis. However, we found that n-3 PUFA rich diet increased NA concentration in PFC. In this regard, it has been reported that genetic enhancement of NA tone protects animals from stress-induced depressive behavior \[[@CR64]\].

Although NAergic transmission in the context of nutritional n-3 deficiency has received little attention, in vitro studies have demonstrated that incorporation of DHA or short exposure to this molecule in SH-SY5Y cultured cells result in increased basal NA release through enhanced exocytosis \[[@CR65]\]. In addition, we can speculate that the effect of n-3 PUFA on noradrenergic system could reflect a neuroprotective phenomenon. Indeed, NA has been shown to regulate glial activation and strategies that lead to increased NA levels have been proposed as a valid approach to cure several neurodegenerative diseases \[[@CR66]\]. In this regard, in vitro studies have evidenced a protective effect of NA toward toxicity induced by Aβ~1--42~ via activation of neurotrophic pathways \[[@CR67], [@CR68]\]. Moreover, reduced NA concentrations in locus coeruleus projecting areas facilitate the inflammatory reaction of microglial cells after Aβ~1--42~ exposure, thus impairing microglial migration and phagocytosis, thereby decreasing Aβ clearance \[[@CR69]\]. Interestingly, it has been reported that n-3 PUFA supply enhances microglial phagocytosis of Aβ~1--42~ \[[@CR70]\]. On the other hand, in our unpublished observation, central Aβ~1--42~ administration leads to enhanced cytokine levels, in particular we found high cortical interleukin-1β (IL-1β) content. Accordingly, we previously described increased hippocampal IL-1β release following local Aβ~1--42~ injection \[[@CR71]\]. Enhanced IL-1β levels have also been linked to late-life depression \[[@CR72]\], as well as Aβ~1--42~ \[[@CR73]\], and central IL-1β is considered crucial for chronic stress-induced depression \[[@CR74]\]. Moreover, high n-3 PUFA diet can reduce IL-1β production \[[@CR75]\] and, in rats, can attenuate IL-1β-induced stress/anxiety response \[[@CR76]\]. In keeping with these data, our in vivo results strongly support such hypothesis, since n-3 PUFA fed animals had decreased plasmatic Aβ~1--42~ levels. Although in humans, plasmatic Aβ~1--42~ is not used as markers of AD diagnosis or progression yet, in rodents it has been finely demonstrated that plasmatic levels reflects cerebrospinal levels in a dose-dependent fashion \[[@CR77]\]. In addition, increased consumption of n-3 PUFA in healthy elderly was associated to lower Aβ~1--42~ plasma levels \[[@CR78]\]. However, this was a cross-sectional study connoted by the fact that nutritional information were taken with a questionnaire and not all nutrients or daily habits were considered. Conversely, in our experimental protocol, many variables were controlled. Animals were subjected to same external conditions, food and body weight were weekly monitored, indicating no differences. Moreover, our animals were fed with these modified diets throughout their life, from conception until adulthood.

Accordingly enough, we found that n-6 PUFA fed rats presented increased Aβ~1--42~ levels. This result may allow several considerations since we have previously demonstrated that a single intracerebroventricular administration of soluble Aβ~1--42~ induces a depressive-like state in rats that is accompanied by reduced cortical 5-HT and BDNF \[[@CR22]\]. In addition, we found an altered HPA axis response after Aβ~1--42~ central administration \[[@CR79]\]. These findings strongly argue in favor of a central role of Aβ~1--42~ in the development of depressive symptoms and our data indicate that this peptide might be crucially involved in behavioral alterations found consequently to high n-6 PUFA intake. Importantly, depression has been associated with prodromal stages of AD \[[@CR80]\] and significantly higher levels of CSF Aβ~1--42~ in humans with major depressive disorder have been reported \[[@CR81]\].

Ultimately, we cannot completely rule out the possibility that such alteration in plasmatic Aβ levels could reflect a peripheral phenomenon considering that platelets have been indicated as a major source of amyloid peptide precursor (APP) \[[@CR82]\] and they possess the enzymatic machinery for APP metabolite production \[[@CR83]\]. However, the central effects found in the present manuscript endorse the hypothesis that high plasmatic Aβ levels can mirror central levels. In this regard, it has been reported that Aβ CSF reflects plasmatic levels in healthy subjects, while in AD patients such equilibrium is disrupted \[[@CR84]\].

To the best of our knowledge, this is the first study linking together the insurgence of depressive and anxiety-like state following lifelong high n-6 PUFA and n-3 deficient diets with increased plasmatic Aβ~1--42~ levels. Important consideration may be drawn. Depressive disorders are very common in western countries and depression during childhood is positively associated with BMI and overweight in later life \[[@CR85], [@CR86]\]. On the other hand, a dramatic increase in AD has been reported in developing countries as consequence of westernization of national diets either in industrialized countries, such as Japan, or developing countries \[[@CR87]\]. In addition, the negative role of n-6 PUFA has been reported in conditions of supplementation of n-3 PUFA. In particular, while supplementing n-3 PUFA is a valid strategy for reversing learning deficit induced by their deficiency, concomitant high n-6 consumption can limit such beneficial effect \[[@CR27]\].

Conclusions {#Sec19}
===========

In conclusion, our results encourage questioning the negative impact that changes in modern lifestyle occurring through years could have in health in western countries, and strongly endorse the protective role of n-3 and the detrimental effect of improper n-6 PUFA consumption.
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